Systemic Therapy for Locally Advanced and Metastatic Cholangiocarcinoma

被引:7
|
作者
Sookprasert, Aumkhae [1 ]
Chindaprasirt, Jarin [1 ]
Wirasorn, Kosin [1 ]
机构
[1] Khon Kaen Univ, Fac Med, Dept Internal Med, Div Oncol, Khon Kaen 40002, Thailand
关键词
Antineoplastic agents; bile duct neoplasms; liver neoplasms; systemic treatment; BILIARY-TRACT CANCER; PHASE-II TRIAL; 5-FU ECF; GEMCITABINE; CHEMOTHERAPY; CISPLATIN; 5-FLUOROURACIL; OXALIPLATIN; COMBINATION; MULTICENTER;
D O I
10.7314/APJCP.2012.13.KKSuppl.3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cholangiocarcinoma, the typical bile duct epithelium neoplasm, is most commonly reported in the Northeast of Thailand. Surgical intervention is the only possible curative treatment in the early stage of disease. Unfortunately, most patients are advanced at the time of diagnosis and not appropriate for curative surgical treatment. The prognosis of advanced CCA is extremely poor and chemotherapy is the only approved treatment for this stage of disease. This article reviews the state-of-art chemotherapy for locally advanced or metastatic cholangiocarcinoma.
引用
收藏
页码:3 / 6
页数:4
相关论文
共 50 条
  • [1] Futibatinib: A Review in Locally Advanced and Metastatic Cholangiocarcinoma
    Hoy, Sheridan M.
    [J]. TARGETED ONCOLOGY, 2024, 19 (03) : 473 - 480
  • [2] Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma - an Austrian expert consensus statement
    Taghizadeh, Hossein
    Djanani, Angela
    Eisterer, Wolfgang
    Gerger, Armin
    Gruenberger, Birgit
    Gruenberger, Thomas
    Rumpold, Holger
    Weiss, Lukas
    Winder, Thomas
    Woell, Ewald
    Prager, Gerald W.
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] Addition of bevacizumab to systemic therapy for locally advanced and metastatic nasopharyngeal carcinoma
    Zhang, Hui-Jie
    Yuan, Gao-Le
    Liang, Qi-Lian
    Peng, Xiao-Xia
    Cheng, Shao-Ang
    Jiang, Liang
    [J]. ONCOLOGY LETTERS, 2018, 15 (05) : 7799 - 7805
  • [4] Management of Locally Advanced or Metastatic Combined Hepatocellular Cholangiocarcinoma
    Zhao, Jemmy
    Stephan-Falkenau, Susann
    Schuler, Markus
    Arndt, Boerge
    [J]. CANCERS, 2023, 15 (03)
  • [5] Systemic Therapy Options for Locally Advanced and Metastatic Myxoid, Dedifferentiated and Pleomorphic Liposarcoma
    Pink, Daniel
    West, Antje
    Andreou, Dimosthenis
    [J]. ZENTRALBLATT FUR CHIRURGIE, 2020, 145 (02): : 160 - 167
  • [6] Recent Progress in the Systemic Treatment of Advanced/Metastatic Cholangiocarcinoma
    Fostea, Raluca Maria
    Fontana, Elisa
    Torga, Gonzalo
    Arkenau, Hendrik-Tobias
    [J]. CANCERS, 2020, 12 (09) : 1 - 12
  • [7] Capecitabine (X) single-agent therapy in patients (pts) with locally advanced/metastatic cholangiocarcinoma
    Sew, O. Sea
    Sookprasert, A.
    Bhudhisawad, V.
    Kaewket, V.
    Pirojkul, C.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 53 - 54
  • [8] Inflammatory cells infiltrate and angiogenesis in locally advanced and metastatic cholangiocarcinoma
    Tamma, Roberto
    Annese, Tiziana
    Ruggieri, Simona
    Brunetti, Oronzo
    Longo, Vito
    Cascardi, Eliano
    Mastropasqua, Mauro Giuseppe
    Maiorano, Eugenio
    Silvestris, Nicola
    Ribatti, Domenico
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 (05)
  • [9] Impact of induction therapy in locally advanced intrahepatic cholangiocarcinoma
    Dhote, Alix
    Tzedakis, Stylianos
    Hobeika, Christian
    Marchese, Ugo
    Coriat, Romain
    Nassar, Alexandra
    Beaufrere, Adrelie
    Codjia, Tatiana
    Goumard, Claire
    Scatton, Olivier
    Dohan, Anthony
    Ronot, Maxime
    Terris, Benoit
    Lesurtel, Mickael
    Dokmak, Safi
    Cauchy, Francois
    Fuks, David
    [J]. EJSO, 2023, 49 (10):
  • [10] Response to systemic therapy in locally advanced and metastatic renal cell carcinoma: can it be predicted?
    Gonzalez, Javier
    Gaynor, Jeffrey J.
    Ciancio, Gaetano
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (06) : 629 - 639